- Previous Close
3.850 - Open
3.100 - Bid 3.220 x --
- Ask 3.250 x --
- Day's Range
3.100 - 3.250 - 52 Week Range
3.020 - 11.680 - Volume
57,800 - Avg. Volume
124,783 - Market Cap (intraday)
1.832B - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.420 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
6.53
Zhejiang Taimei Medical Technology Co., Ltd. provides digital operation platform for the biopharma industry in China. The company offers TrialOS, a drug digital cooperation platform that connects the cycle of hospitals, pharmaceutical companies, third-party providers, regulatory authorities, patients, and other industry stakeholders. It offers software solutions, such as eCooperate, a clinical trial cooperation platform that optimizes clinical research operations management systems, as well as support decision-making with big data technology; eArchives, a clinical trial master file system; eCollect, an electronic data capture system; eCollege, a training management system; eQuality, an electronic quality audit system; eBalance, an interactive Web-based response system; eVisit Patient Reported Outcomes, a solution that enhances the ability of patients to enter data and the accuracy of clinical trial data; eTime, a project man-hour management system; and eImage, a medical image reading system. It also provides hospital software, including eTrial, a phase I ward management system; eSite, a clinical trial management system for GCP sites; GCP-X, an intelligent clinical trial platform; NomenCTMS, a clinical research project management system for GCP sites; eScreening, a subject information management and duplicate checking system; Intelligent Investigator, an initiated clinical trial platform; IIT-EDC, a clinical research data management platform; and Investigator-Initiated Clinical Trial Management System, a project management system. In addition, the company offers pharmacovigilance software solutions, such as eSafety global pharmacovigilance system; eSafety, an intelligent professional information system for pharmacovigilance; and SAE Manager, a safety data communication and management system for clinical trials. Further, it provides marketing software and digital innovation solutions. The company was founded in 2013 and is headquartered in Jiaxing, China.
www.taimei.com627
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 2576.HK
View MorePerformance Overview: 2576.HK
Trailing total returns as of 4/7/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 2576.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2576.HK
View MoreValuation Measures
Market Cap
2.17B
Enterprise Value
924.07M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.55
Price/Book (mrq)
1.75
Enterprise Value/Revenue
1.57
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-38.94%
Return on Assets (ttm)
-10.02%
Return on Equity (ttm)
-19.10%
Revenue (ttm)
551.16M
Net Income Avi to Common (ttm)
-214.61M
Diluted EPS (ttm)
-0.420
Balance Sheet and Cash Flow
Total Cash (mrq)
978.7M
Total Debt/Equity (mrq)
1.34%
Levered Free Cash Flow (ttm)
--